These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 33737202)

  • 1. Sublingual vaccination and delivery systems.
    Paris AL; Colomb E; Verrier B; Anjuère F; Monge C
    J Control Release; 2021 Apr; 332():553-562. PubMed ID: 33737202
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intranasal and sublingual delivery of inactivated polio vaccine.
    Kraan H; Soema P; Amorij JP; Kersten G
    Vaccine; 2017 May; 35(20):2647-2653. PubMed ID: 28400164
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Buccal and sublingual vaccine delivery.
    Kraan H; Vrieling H; Czerkinsky C; Jiskoot W; Kersten G; Amorij JP
    J Control Release; 2014 Sep; 190():580-92. PubMed ID: 24911355
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Natural killer T cell and TLR9 agonists as mucosal adjuvants for sublingual vaccination with clade C HIV-1 envelope protein.
    Singh S; Yang G; Byrareddy SN; Barry MA; Sastry KJ
    Vaccine; 2014 Dec; 32(51):6934-6940. PubMed ID: 25444819
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sublingual immunization with a subunit influenza vaccine elicits comparable systemic immune response as intramuscular immunization, but also induces local IgA and TH17 responses.
    Gallorini S; Taccone M; Bonci A; Nardelli F; Casini D; Bonificio A; Kommareddy S; Bertholet S; O'Hagan DT; Baudner BC
    Vaccine; 2014 Apr; 32(20):2382-8. PubMed ID: 24434044
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sublingual mucosa: A new vaccination route for systemic and mucosal immunity.
    Kweon MN
    Cytokine; 2011 Apr; 54(1):1-5. PubMed ID: 21239178
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lipid-Based Particles: Versatile Delivery Systems for Mucosal Vaccination against Infection.
    Corthésy B; Bioley G
    Front Immunol; 2018; 9():431. PubMed ID: 29563912
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sublingual delivery of vaccines for the induction of mucosal immunity.
    Shim BS; Choi Y; Cheon IS; Song MK
    Immune Netw; 2013 Jun; 13(3):81-5. PubMed ID: 23885221
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Induction of mycobacterial protective immunity by sublingual BCG vaccination.
    Eickhoff CS; Blazevic A; Killoran EA; Morris MS; Hoft DF
    Vaccine; 2019 Aug; 37(36):5364-5370. PubMed ID: 31331776
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Buccal and Sublingual Vaccines: A Review on Oral Mucosal Immunization and Delivery Systems.
    Trincado V; Gala RP; Morales JO
    Vaccines (Basel); 2021 Oct; 9(10):. PubMed ID: 34696284
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Simultaneous approach using systemic, mucosal and transcutaneous routes of immunization for development of protective HIV-1 vaccines.
    Belyakov IM; Ahlers JD
    Curr Med Chem; 2011; 18(26):3953-62. PubMed ID: 21824096
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mucoadhesive Vaccine Delivery Systems for the Oral Mucosa.
    Mokabari K; Iriti M; Varoni EM
    J Dent Res; 2023 Jul; 102(7):709-718. PubMed ID: 37148290
    [TBL] [Abstract][Full Text] [Related]  

  • 13. B cell and T cell immunity in the female genital tract: potential of distinct mucosal routes of vaccination and role of tissue-associated dendritic cells and natural killer cells.
    Anjuère F; Bekri S; Bihl F; Braud VM; Cuburu N; Czerkinsky C; Hervouet C; Luci C
    Clin Microbiol Infect; 2012 Oct; 18 Suppl 5():117-22. PubMed ID: 22882377
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mucosal delivery routes for optimal immunization: targeting immunity to the right tissues.
    Czerkinsky C; Holmgren J
    Curr Top Microbiol Immunol; 2012; 354():1-18. PubMed ID: 21053117
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mucosal responses to parenteral and mucosal vaccines.
    Kaul D; Ogra PL
    Dev Biol Stand; 1998; 95():141-6. PubMed ID: 9855424
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Overview and Future Potential of Fast Dissolving Buccal Films as Drug Delivery System for Vaccines.
    Uddin MN; Allon A; Roni MA; Kouzi S
    J Pharm Pharm Sci; 2019; 22(1):388-406. PubMed ID: 31386612
    [TBL] [Abstract][Full Text] [Related]  

  • 17. New insights in mucosal vaccine development.
    Pavot V; Rochereau N; Genin C; Verrier B; Paul S
    Vaccine; 2012 Jan; 30(2):142-54. PubMed ID: 22085556
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mucosal vaccines: a paradigm shift in the development of mucosal adjuvants and delivery vehicles.
    Srivastava A; Gowda DV; Madhunapantula SV; Shinde CG; Iyer M
    APMIS; 2015 Apr; 123(4):275-88. PubMed ID: 25630573
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mucosal vaccines: Strategies and challenges.
    Li M; Wang Y; Sun Y; Cui H; Zhu SJ; Qiu HJ
    Immunol Lett; 2020 Jan; 217():116-125. PubMed ID: 31669546
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mucosal immunization: a review of strategies and challenges.
    Patel H; Yewale C; Rathi MN; Misra A
    Crit Rev Ther Drug Carrier Syst; 2014; 31(4):273-303. PubMed ID: 25072196
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.